Lauren Colleen Wagoner, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5200 Hahns Peak Dr, Loveland, CO 80538 Phone: 307-286-3288 Fax: 970-962-4901 |
Isabelle Torsiello Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1250 N Wilson Ave, Loveland, CO 80537 Phone: 970-494-4200 Fax: 970-613-4475 |
Ms. Kimberley Sue Roberts, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 3461 Oberon Dr, Loveland, CO 80537 Phone: 319-350-5708 |
Matthew W Long, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 832 W Eisenhower Blvd Ste B5, Loveland, CO 80537 Phone: 970-430-6751 |
Joseph Edward Davison, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4575 Byrd Dr, Loveland, CO 80538 Phone: 630-917-5729 |
Jennifer G Schleinkofer, LSCW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1762 Hoffman Dr, Loveland, CO 80538 Phone: 970-541-1006 |
Ryan Wilson, L.S.W Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1905 W 8th St, #209, Loveland, CO 80537 Phone: 970-775-7061 |
Megan Leann Schalembier Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2205 Albany Ct, Loveland, CO 80538 Phone: 720-275-7996 |
Kathryn N Romeo, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 821 Duffield Ct, Loveland, CO 80537 Phone: 888-948-6789 |
Nicole Alexander, MSW, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1250 N Wilson Ave, Loveland, CO 80537 Phone: 970-494-4200 |
Keith Colton, LCSW, MSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1250 N Wilson Ave, Loveland, CO 80537 Phone: 970-494-4200 |
Jenny Elizabeth Fox-tabor Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1946 White Ibis Ct, Loveland, CO 80537 Phone: 970-689-1889 |
Ms. Julie Lynn Ferguson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2719 Logan Dr, Loveland, CO 80538 Phone: 970-825-8040 |
Mrs. Sandra S Lee, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1635 Foxtrail Dr, Loveland, CO 80538 Phone: 970-541-9590 |
Ms. Elise Christine Smith, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1440 W 29th St, #100, Loveland, CO 80538 Phone: 971-775-7061 Fax: 907-292-8194 |
Amy Christine Windschitl, LCSW, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4575 Byrd Dr, Loveland, CO 80538 Phone: 970-361-5126 Fax: 970-433-3755 |
Jessica Marie Shiveley Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 323 E 27th St, Loveland, CO 80538 Phone: 970-541-1015 |
Tommie Lou Robinson, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 221 E 29th St Ste 102, Loveland, CO 80538 Phone: 970-203-7050 Fax: 970-203-7055 |
Mary Elizabeth Swanson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1440 W 29th St Ste 100, Loveland, CO 80538 Phone: 970-581-5155 |
Jennifer Kim Pries, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 323 E 27th St, Loveland, CO 80538 Phone: 720-202-5326 |
News Archive
Mylan Inc. today confirmed that a federal district court has granted its request to enforce a settlement agreement between Endo Pharmaceuticals and Mylan settling patent litigation in connection with Mylan's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration for Frovatriptan Succinate Tablets, 2.5 mg.
Insmed Incorporated, a biopharmaceutical company, today announced that it has begun screening patients for its U.S. phase 2 clinical trial, Treatment with ARIKACE to Realize Greater Efficacy Trial (TARGET-NTM), of ARIKACE (liposomal amikacin for inhalation) in patients with non-tuberculous mycobacterial (NTM) lung disease.
Semafore Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's SF1126 product candidate for the treatment of B-cell chronic lymphocytic leukemia (CLL). In April 2010, the Company initiated an expansion of its ongoing Phase I clinical study into this disease setting. SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR).
A novel approach to detecting and targeting flaws in first line of defense against cancer has earned an Era of Hope Scholar Award from the U.S. Department of Defense for a scientist at The University of Texas M. D. Anderson Cancer Center.
› Verified 1 days ago